BactiQuant A/S: Financial statements 2012
CVR: 24231712
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
BactiQuant A/S (CVR 24231712) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 5,618,809 and a net result of DKK 2,064,349. Equity in the 2012 report amounted to DKK 6,064,090. The solvency ratio was 81.5%.
- Gross Profit
- DKK 5,618,809
- Profit/Loss
- DKK 2,064,349
- Equity
- DKK 6,064,090
- Total Assets
- DKK 7,444,211
Official annual report
Keep an eye on BactiQuant A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BactiQuant A/S
BactiQuant A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1999. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MYCOMETER A/S and MYCOMETER ApS. The management consists of Morten Miller, Henrik Brian Sønderup Sørensen and Murugasan Claes Nielsen. The board consists of Henrik Skaanderup (chair), Daniel Patterson and Søren Ulstrup. The company is owned by Murugasan Claes Nielsen and MVA & CO HOLDING ApS. The company has 21 employees (2026). In 2025, the company reported revenue of DKK 8,318,567 and a net result of DKK -13,833,117 compared with DKK -13,722,560 the year before. Equity in the 2025 report amounted to DKK 17,260,615.